The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.
 
Purvi Shah
No Relationships to Disclose
 
Vasily Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Joe Ensor
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Stephanie Sanchez
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Christopher Wang
No Relationships to Disclose
 
Timothy Cannon
Honoraria - AstraZeneca; Bayer; Sirflex; Sirflex
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare
 
Lyudmyla Berim
No Relationships to Disclose
 
Trevor Feinstein
Leadership - OneOncology
Consulting or Advisory Role - Bayer; Bayer; Deciphera; Genzyme; Gilead Sciences; Lilly; Nektar
Speakers' Bureau - Sanofi; SOBI
Travel, Accommodations, Expenses - BeyondSpring Pharmaceuticals
 
Axel Grothey
Honoraria - Cardinal Health; Total Health Conferencing
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); Daiichi Sankyo (Inst); Guardant Health (Inst); Lilly (Inst); Natera (Inst); OBI Pharma; Replimune (Inst)
Research Funding - Caris Life Sciences (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Guardant Health (Inst); Lilly (Inst); Natera (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Total Health Conferencing
 
Joseph McCollom
No Relationships to Disclose
 
Sujith Kalmadi
No Relationships to Disclose
 
Ahmed Zakari
Consulting or Advisory Role - Ipsen
Speakers' Bureau - AstraZeneca; Geron; Incyte; Taiho Pharmaceutical
 
Farshid Dayyani
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Astellas Pharma; Exelixis; ipsen; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Don Gravenor
No Relationships to Disclose
 
Minetta Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Adham Jurdi
Employment - Natera
Stock and Other Ownership Interests - Agenus; Cardiff Oncology; Iovance Biotherapeutics; natera
 
Alexey Aleshin
Employment - Natera
Leadership - Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Mission Bio
Travel, Accommodations, Expenses - Natera
 
Janelle Meyer
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BillionToOne (Inst); BillionToOne (Inst); Biodesix (Inst); Celcuity (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Natera (Inst); Tempus (Inst); VastBiome (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Up To Date
Travel, Accommodations, Expenses - Exigent Research
 
Saima Sharif
Research Funding - GlaxoSmithKline
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Lutris; Navire
Consulting or Advisory Role - Agenus; Amgen; AmMax Bio; Arcus Biosciences; AstraZeneca; AVEO; Bayer Health; BeiGene; Boehringer Ingelheim; Bridgebio; Bristol-Myers Squibb/Medarex; Carina Biotech; Clasp Therapeutics; Cytovation; Dewpoint Therapeutics; EMD Serono; Flame Biosciences; Frontier Medicines; Genentech; Harbinger Oncology, Inc; Ikena Oncology; Kestrel Therapeutics; Marengo Therapeutics; Merck; Mirati Therapeutics; Pfizer; Replimune; Revolution Medicines; Roche; SageMedic; SERVIER; Sibylla; T-Cypher Bio; Tachyon Therapeutics; XAIRA Therapeutics; Zentalis; Zentalis
Research Funding - Amgen; Boehringer Ingelheim; BridgeBio; Daiichi Sankyo; EMD Serono; Genentech/Roche; Guardant Health; Lilly; Pfizer; Zentalis